Clinical trial
A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
NCT00460954 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00460954 |
|---|---|
| Title | A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects |
| Official title | An Open Label, Multiple-Dose Study ot Determine the Plasma Levodopa Profiles of Sinemet® CR (Carbidopa/Levodopa) at 4 Daily Dose Levels in Healthy Subjects |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Sinemet® controlled release (Carbidopa/levodopa) |
| Enrollment | 20 |
| Start date | Jun 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 17, 2007 |
| Last update posted | Aug 14, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: